34684-21-4Relevant articles and documents
-
Humphreys
, p. 203 (1901)
-
-
Remsen,Saunders
, p. 347 (1895)
-
-
Bucher
, p. 349 (1895)
-
METHODS OF TREATING LIVER DISEASES
-
Paragraph 00392, (2014/05/24)
The invention provides tricyclic compounds and their use in treating liver disorders, such as non-alcoholic steatohepatitis and related disorders (e.g., fibrosis). The compounds are contemplated to have activity against methionyl aminopeptidase 2.
NUCLEOPHILE ASSISTING LEAVING GROUPS
-
Page/Page column 20-23, (2010/11/08)
Sulfonate leaving groups include a cation chelating moiety, e.g. a polyether or crown ether. The chelating moiety stabilizes the sulfonate leaving group by forming a complex with a cation of a cation-nucleophile combination. The stabilized leaving group is more easily displaced under many conditions than are standard arylsulfonate leaving groups such as the toxyl group. The chelating moiety also favors certain cations depending on the identity of the moiety thereby enhancing the reaction rate with nucleophilic salts containing the preferred cation. Use of the inventive leaving groups results in improved yields, decreased reaction times and improved product purity.